Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience

Taylor and Francis Group, Journal of Dermatological Treatment, 1(34), 2023

Journal article published in 2023 by Silvia Ferrucci

, Francesca Barei, Simona Tavecchio, Angelo V. Marzano, Martina Zussino, Luigi Naldi, Elena Pezzolo

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by